Results of phase 2 trial of eritoram, a synthetic TLR-4 antagonist, in patients with severe sepsis

Authors

Mark Tidswell MD, Baystate HealthFollow

Author Department

Medicine

Document Type

Presentations, Research

Publication Date

2-1-2007

Recommended Citation

Society of Critical Care Medicine 36th Critical Care Congress 2007 Feb. Crit Care Med 2006;34:7.